Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.

Patients 111

Patients DEA Research and Development Recreational 111

NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 198

DEA Cultivation Compliance Compliance 198

Americans for Safe Access

MARCH 12, 2025

Watch as we explore the significance of the last 12 years in establishing cannabis' "currently accepted medical use" and learn why this matters! Watch as we explore the significance of the last 12 years in establishing cannabis' "currently accepted medical use" and learn why this matters!

DEA 130

DEA Policy Cannabis 130

NORML

JANUARY 15, 2020

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. It’s past time for Congress to catch up with the American people.”

Policy 199

Policy DEA Legislation Data 199

NORML

MARCH 25, 2025

"Although Congress has failed to amend federal cannabis laws to explicitly recognize state-legal cannabis markets, the attitudes and priorities of federal law enforcement agents and prosecutors have clearly shifted in a manner that reflects their reality.

Marijuana 219

Marijuana Policy Law Legalization 219

NORML

MARCH 26, 2020

For the second time in four years, the US Drug Enforcement Administration is proposing regulatory changes to procedures governing the federally licensed manufacture of cannabis for clinical research purposes. The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants.

Cultivation 244

Cultivation DEA Extraction THC 244

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 199

DEA Research and Development Clinical Trials Marijuana 199

Project CBD

MARCH 7, 2025

13 by the San Diego/Imperial Counties Joint Labor Management Cannabis Committee made up of representatives of UFCW Local 135 , and local companies March & Ash and Embarc. What’s more, synthesized Delta-9 THC is present in many of these products, despite being prohibited in both California’s cannabis and hemp programs.

Hemp 232

Hemp Vaping THC Cannabinoids 232

NORML

OCTOBER 21, 2019

A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.

DEA 104

DEA Cultivation Clinical Trials Policy 104

NORML

JULY 15, 2020

Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.". The post Survey: Majority of Health Care Professionals Endorse Cannabis Use Instead of Opioids in Chronic Pain Patients appeared first on NORML.

Chronic Pain 246

Chronic Pain Patients DEA Marijuana 246

Cannabis Law Report

SEPTEMBER 1, 2021

The lawsuit—filed last year by cannabis researcher Sue Sisley of the Scottsdale Research Institute, the Battlefield Foundation and veterans Lorenzo Sullivan and Gary Hess— received oral arguments in June and largely centers on DEA’s 2020 denial of a one-page marijuana rescheduling petition filed by a separate individual.

DEA 109

DEA Marijuana Policy Cannabis 109

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.

Clinical Trials 234

Clinical Trials Legislation DEA Patients 234

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling. That one was granted.

DEA 108

DEA Marijuana History Cannabis 108

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

JANUARY 13, 2020

This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Witnesses will be: Matthew J.

Legislation 197

Legislation Marijuana Policy DEA 197

The Blunt Truth

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 98

DEA Data Decriminalization Legalization 98

Americans for Safe Access

APRIL 2, 2019

The Americans for Safe Access 2019 Unity Conference, themed The Price of Being a Medical Cannabis Patient, featured over a hundred patients from all over America visiting their representatives in Congress and the Senate to promote the Medical Cannabis Control Act of 2019. Which agency will have authority over medical cannabis policy?

Access 124

Access DEA Policy Patients 124

WeedAdvisor

AUGUST 28, 2019

As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Veriheal

JANUARY 16, 2024

Although there have been rumors circulating for some time regarding the potential rescheduling of cannabis, it wasn’t confirmed until recently that this is becoming a genuine possibility. With cannabis’ current status as a Schedule I drug, it’s challenging for the federal government to push for nationwide legalization.

DEA 122

DEA Medicine Cannabis Legalization 122

Cannabis Law Report

AUGUST 24, 2020

August 24, 2020 The DEA has not issued a warning or otherwise signaled a change in enforcement policy by issuing the interim final rule. The post Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp first appeared on Cannabis Law Report. On … Read More.

DEA 59

DEA Hemp Marijuana Policy 59

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? Cannabis offers significant therapeutic benefits for a wide range of medical conditions. MAPS worked for over 22 years to obtain marijuana for medical marijuana drug development research, and the approval is a historic shift in federal policy. 5 cannabis strains to treat PTSD: 1.

Strains 190

Strains Indica Hybrid Research and Development 190

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. In other words, the feds are ending their monopoly on cannabis grown for scientific purposes. cannabis researchers. cannabis researchers.

DEA 52

DEA Research and Development Data Cannabis 52

SpeedWeed

MAY 11, 2021

The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. According to the data published in the DEA’s yearly Domestic Cannabis Eradication/Suppression Program Statistical Report, approximately 4.54

DEA 52

DEA Marijuana Data Programs 52

CannaMD

JULY 19, 2020

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. At the same time, however, the number of illegal cannabis plants seized by the agency spiked. Let’s take a closer look at what DEA data reveals. Cannabis Users Left Alone. Illicit Grow Ops Targeted.

DEA 59

DEA Marijuana Data Decriminalization 59

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

CannaMD

MARCH 26, 2024

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 98

DEA Marijuana Therapy Policy 98

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). Given the alarming and noticeable increase in ayahuasca border seizures in 2020, the main intent of these initial requests was to see how many seizures happened that year and if the government had a specific policy regarding these seizures. Customs Border Patrol (“CBP”) and U.S. 562 [2011]).

DEA 97

DEA Blood Pressure Safety Policy 97

Veriheal

JULY 29, 2021

Following the recent news of Texan sprinter Sha’Carri Richardson returning a positive test for cannabis, a debate has erupted on the topic of cannabis as a performance-enhancing drug – can the plant enhance agility, strength, and/or speed? Olympic Snowboarder Previously Regained Medal After Consuming Cannabis.

DEA 98

DEA Cannabis Cannabinoids Sativa 98

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 85

DEA Hemp Cultivation Advocacy 85

NORML

APRIL 30, 2024

“It is significant for these federal agencies, and the DEA and FDA in particular, to acknowledge publicly for the first time what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans.”

DEA 359

DEA Patients Cannabis Policy 359

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. The men and women who served in the U.S. Armed Forces often face difficult physical and mental challenges upon returning home.

DEA 104

DEA Chronic Pain Treatment Therapy 104

The Blunt Truth

APRIL 2, 2020

Of course, what’s happening in the cannabis world is what’s happening everywhere else: the coronavirus. Governor Kristi Noem has overcome her reluctance to allow any form of cannabis in her state, and signed a bill allowing the growth, production and transportation of hemp. DEA GUIDANCE. SOUTH DAKOTA.

DEA 101

DEA Hemp Packaging Recreational 101

SpeedWeed

MARCH 4, 2021

In the 2020 National Drug Threat Assessment , which was released by the DEA on Wednesday, the agency notes that despite its continued illegality under federal law, marijuana “is the most commonly used illicit drug in the United States.”. This has led to the saturation of some markets, particularly in states that have legalized cannabis.

DEA 52

DEA Supply Chain Advocacy Recreational 52

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

The Blunt Truth

OCTOBER 15, 2019

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% We had previously blogged on The Stoned Age: What the CBD Craze Means for Employers and Their Substance Abuse Policies , CBD is Everywhere – But Where Does the FDA Stand? ,

THC 87

THC CBD DEA Policy 87

SpeedWeed

MARCH 10, 2021

Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.

DEA 52

DEA Hemp Cannabinoids Legalization 52

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 111

Cultivation Data DEA Dispensary 111